Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2025 Oct 15:253:78-85.
doi: 10.1016/j.amjcard.2025.06.002. Epub 2025 Jun 8.

6 Year Follow-Up of Balloon-Expandable Versus Self-Expanding Transcatheter Aortic Valves: A Propensity-Matched Analysis

Affiliations
Free article
Comparative Study

6 Year Follow-Up of Balloon-Expandable Versus Self-Expanding Transcatheter Aortic Valves: A Propensity-Matched Analysis

Zade Bihag et al. Am J Cardiol. .
Free article

Abstract

Prior reports comparing long-term outcomes of balloon-expandable (BE) versus self-expanding (SE) transcatheter aortic valve implantation (TAVI) have been limited. We compared in-hospital, 1-year, and 6-year outcomes in 1,685 BE (S3, Ultra) versus 776 SE (Evolut R, PRO, PRO+) patients undergoing transfemoral TAVI at a single center. Valve-in-valve and nontransfemoral access cases were excluded. Propensity-score matched BE (n = 683) and SE (n = 680) cohorts did not differ with respect to age (82.2 ± 8.0 vs 82.1 ± 7.8 years, p = 0.407), baseline demographics and comorbidities, pre-TAVI echo and cardiac catheterization results, and STS Risk Score (7.9 ± 5.9 vs 7.9 ± 5.5%, p = 0.481). BE vs SE patients had similar in-hospital mortality (0.9 vs 0.6%, p = 0.0.072), stroke (1.3 vs 1.8%, p = 0.503), major vascular complications (2.8 vs 2.2%, p = 0.495) and composite bleeding (4.7 vs 3.4%, p = 0.178), although the BE cohort required fewer permanent pacemakers (8.3 vs 13.3%, p = 0.003). At 1-year, BE and SE patients had similar all-cause mortality (10.8 vs 11.2%, p = 0.825), hospital readmission (22.5 vs 19.6%, p = 0.192), and KCCQ12 scores (83.7 ± 25.5 vs 83.0 ± 24.6, p = 0.606). At a median follow-up of 77.0 (72.6 to 81.5) months, Kaplan-Meier survival analysis demonstrated no difference in BE vs SE all-cause mortality (33.2 vs 40.4%, p = 0.586), with no differences in late valve-related outcomes including myocardial infarction, stroke, AV endocarditis, and AV re-intervention (balloon aortic valvuloplasty, percutaneous paravalvular leak closure, repeat TAVI, surgical AV replacement). However, BE patients more commonly required treatment for subclinical leaflet thrombosis, while SE patients had a higher incidence of transient ischemic attack during follow-up. In conclusion, BE and SE TAVI patients have similar in-hospital, 1-year and median 6-year adverse outcomes, other than higher subclinical leaflet thrombosis in BE patients and an increased transient ischemic attack rate in SE patients.

Keywords: balloon-expandable valve; self-expanding valve; transcatheter aortic valve implantation.

PubMed Disclaimer

Conflict of interest statement

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Publication types

LinkOut - more resources